Merative MarketScan

Partner Content

HEOR explained: Improving healthcare decisions with real-world evidence

How longitudinal, closed claims data is advancing regulatory, epidemiology, and health economics and outcomes research (HEOR).

News

FDA issues guidance on using real-world data for drug development

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Sections

Sections

Sections

Sections

Sections

HEOR explained: Improving healthcare decisions with real-world evidence

FDA issues guidance on using real-world data for drug development

Leading Account and Intent-Based Sales and Marketing Providers and Technology Solutions for the Pharmaceutical Industry

Leading Sales and Marketing Intent Data, Database and Data Enrichment Providers and Technology Solutions for the Pharmaceutical Industry

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief